Genmab AS (Denmark) Probability of Future Stock Price Finishing Over 1360.5

GMAB Stock  DKK 2,008  22.00  1.08%   
Genmab AS's future price is the expected price of Genmab AS instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Genmab AS performance during a given time horizon utilizing its historical volatility. Check out Genmab AS Backtesting, Genmab AS Valuation, Genmab AS Correlation, Genmab AS Hype Analysis, Genmab AS Volatility, Genmab AS History as well as Genmab AS Performance.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
  
Please specify Genmab AS's target price for which you would like Genmab AS odds to be computed.

Genmab AS Target Price Odds to finish over 1360.5

The tendency of Genmab Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay above kr 1,360  in 90 days
 2,008 90 days 1,360 
close to 99
Based on a normal probability distribution, the odds of Genmab AS to stay above kr 1,360  in 90 days from now is close to 99 (This Genmab AS probability density function shows the probability of Genmab Stock to fall within a particular range of prices over 90 days) . Probability of Genmab AS price to stay between kr 1,360  and its current price of kr2008.0 at the end of the 90-day period is about 55.26 .
Assuming the 90 days trading horizon Genmab AS has a beta of -0.6. This usually indicates as returns on the benchmark increase, returns on holding Genmab AS are expected to decrease at a much lower rate. During a bear market, however, Genmab AS is likely to outperform the market. Additionally Genmab AS has an alpha of 0.0848, implying that it can generate a 0.0848 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Genmab AS Price Density   
       Price  

Predictive Modules for Genmab AS

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genmab AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genmab AS's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2,0062,0082,010
Details
Intrinsic
Valuation
LowRealHigh
1,6821,6842,209
Details
Naive
Forecast
LowNextHigh
1,9931,9951,997
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,9782,0362,093
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genmab AS. Your research has to be compared to or analyzed against Genmab AS's peers to derive any actionable benefits. When done correctly, Genmab AS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genmab AS.

Genmab AS Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Genmab AS is not an exception. The market had few large corrections towards the Genmab AS's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genmab AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genmab AS within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.08
β
Beta against NYSE Composite-0.6
σ
Overall volatility
71.12
Ir
Information ratio -0.02

Genmab AS Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Genmab Stock often depends not only on the future outlook of the current and potential Genmab AS's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Genmab AS's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding66 M
Cash And Short Term Investments19.3 B

Genmab AS Technical Analysis

Genmab AS's future price can be derived by breaking down and analyzing its technical indicators over time. Genmab Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Genmab AS. In general, you should focus on analyzing Genmab Stock price patterns and their correlations with different microeconomic environments and drivers.

Genmab AS Predictive Forecast Models

Genmab AS's time-series forecasting models is one of many Genmab AS's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Genmab AS's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Genmab AS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Genmab AS's short interest history, or implied volatility extrapolated from Genmab AS options trading.
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out Genmab AS Backtesting, Genmab AS Valuation, Genmab AS Correlation, Genmab AS Hype Analysis, Genmab AS Volatility, Genmab AS History as well as Genmab AS Performance.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Genmab Stock analysis

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.